Advanced search×
×

Cancer

Print ISSN
0008-543X
Electronic ISSN
1097-0142
Impact factor
5.131
Publisher
wiley
URL
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0142
Usage rank
26
Article count
37694
Free count
5957
Free percentage
0.158036
PDFs via platforms
Proquest, Rcgp, CSA, Ingenta, Wiley from 1948, Gale, and Ovid from 2005

  1. Magnetic resonance imaging in patients with newly diagnosed breast cancer: A review of the literature.

    Cancer 120(14):2080 (2014) PMID 24752817

    We review the current use of breast MRI and the impact of MRI on short-term surgical outcomes and rates of local recurrence. In addition, we address the use of MRI in specific patient populations, such as those with ductal carcinoma in situ, invasive lobular carcinoma, and occult primary breast canc...
  2. Cancer patients' perceptions regarding the value of the physical examination: A survey study.

    Cancer 120(14):2215 (2014) PMID 24899511

    I believe my experience while being examined has been overall: very negative (a score of -5) to very positive (a score of +5),"-was analyzed using the Sign test. Other items were predefined as either symbolic or pragmatic statements, and patient responses from strongly disagree (a score of 1) to str...
  3. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in ...

    Cancer 120(13):2060 (2014) PMID 24692108

    These results reflect the importance of optimal locoregional therapy in patients with stage III NSCLC and provide motivation for further study of advanced RT technologies in patients with NSCLC. Cancer 2014;120:2060-2068. © 2014 American Cancer Society. © 2014 American Cancer Society....
  4. The overexpression of 14-3-3ζ and Hsp27 promotes non–small cell lung cancer progression.

    Cancer 120(5):652 (2014) PMID 24804299

    The 14-3-3ζ protein has been identified as a putative oncoprotein in several cancers, including non–small cell lung cancer (NSCLC). However, the mechanisms underlying its functions have not been well defined. Proteins that interact with 14-3-3ζ were identified through coimmunoprecipitation and mass...
  5. Consensus statement released for treating melanoma patients with immunotherapy.

    Cancer 120(1):3 (2014) PMID 24347380

  6. Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis.

    Cancer 119(5):1004 (2013) PMID 23132729

    The promoter of Id4 was methylated in 23 of 62 (37%) GBMs. In methylated GBMs, Id4 mRNA was significantly reduced, compared with unmethylated GBMs (P = .0002). A significant reduction of protein expression was detected in all hypermethylated cases. GBMs with methylated Id4 showed a significant reduc...
  7. Dramatic rise in skin cancer seen in young adults.

    Cancer 118(16):3881 (2012) PMID 22864931

  8. Validation of the Royal Marsden Hospital prognostic score in patients treated in the Phase I Clinical Trials Program at the MD Anderson Canc...

    Cancer 118(5):1422 (2012) PMID 21823111

    For patients with lung, pancreatic, and head and neck tumors who were treated on phase 1 trials, survival was predicted accurately by the RMH prognostic score. Cancer 2011;. © 2011 American Cancer Society. Copyright © 2011 American Cancer Society....
  9. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patient...

    Cancer 118(5):1457 (2012) PMID 21837676

    The final QLQ-BM22 module contains 22 items and 4 scales assessing Painful Sites, Painful Characteristics, Functional Interference, and Psychosocial Aspects. Results confirmed the validity, reliability, cross-cultural applicability, and sensitivity of the 22-item EORTC QLQ-BM22. It is therefore reco...
  10. Clinical outcomes of oncologic gastrointestinal resections in patients with cirrhosis.

    Cancer 118(14):3494 (2012) PMID 22170573

    Resection of GI malignancy in cirrhotics is associated with poor early postoperative and transitional outcomes, with severity of liver disease being the primary determinant of postoperative mortality. These data suggest that GI cancer operations can be performed safely in well-selected cirrhotic pat...